J&J loses bid to dismiss false advertising lawsuit over baby products

Carly Helfand Johnson & Johnson was hoping to put a marketing case around its Bedtime Products for babies to rest, but a federal judge isn't having it. FiercePharma News

FDA bans products from China plant used by Big Pharma players

Emily Wasserman A Chinese ingredient maker who has produced ingredients for some of the big guns in pharma including Novartis, Sanofi and Pfizer is getting its products banned by the ...

GSK says people and products were never in danger from Legionella bacteria in cooling towers

Eric Palmer GlaxoSmithKline says that the people and products at its manufacturing site in Zebulon, NC, were never in peril from the bacteria for Legionnaires' disease detected ...

Impax gets products, manufacturing with $700M deal for allergy-drug makers

Carly Helfand Back in August, Impax Laboratories CEO Fred Wilkinson told investors on a conference call that the company was "well-positioned to execute on a number of transactions." ...

Valeant completes sale of products to Nestle for $1.4B

Eric Palmer Nestlé will grab North American rights for antiwrinkle treatments Restylane, Perlane, Emervel and Dysport. FiercePharma News

Sanofi tiptoes toward selling some older products

Carly Helfand Back in April, Sanofi was said to be considering some spring cleaning, weighing a sale of older products to make room for the bolt-on deals CEO Chris Viehbacher wants ...

Glaxo seeks buyers for older products worth up to $12.6B

Carly Helfand GlaxoSmithKline has already made some moves to sell off some of its older meds. But now, it's making more that could end up much, much bigger. FiercePharma News

FDA and hospitals are scrambling as the shortage of hydration products deepens

Eric Palmer The FDA has worked to face down shortages of important, sometimes life-saving, drugs that have sprung up in recent years. But occasionally something as mundane as saline ...

Allergan bags neurotoxin products in $362M licensing deal with Medytox

John Carroll Building on its expertise in neurotoxins, Allergan has in-licensed some new product candidates in a deal with Korea's Medytox. Allergan is paying $ 65 million upfront, ...

Cancer Therapy Products Dominate Advertising Pages of Professional Health Journals

mia.burns By Mia Burns In the first half of this year, advertisers in professional health journals purchased about 45,829 total pages, according to Kantar Media Healthcare Research. ...

U.K. recalls 16 Wockhardt drugs, bans products from Indian plant

Eric Palmer Wockhardt's regulatory quagmire has gotten stickier for a plant where regulators found evidence that some training records were falsified. The U.K. today announced  a ...

FDA warning letter cites Baxter for mold at plant, hair in infusion products

Eric Palmer The FDA has sent Baxter International a warning letter laying out problems it found during inspections at a plant in North Carolina as well as at a plant in Jayuya, Puerto ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS